Institutional investors purchased a net $13.9 million shares of OPK during the quarter ended December 2015. This may signal that the smart money is gaining interest in this company as the 21.89% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SIMPLEX TRADING LLC Bought 51.3 Thousand shares of OPKO Health Inc
VIRTUS INVESTMENT ADVISERS, INC. Bought 45.4 Thousand shares of OPKO Health Inc
MIZUHO SECURITIES USA, INC. Bought 35.3 Thousand shares of OPKO Health Inc